Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alyssa Bradshaw"'
Autor:
Georgia Kaufman, Jorge Jimenez, Alyssa Bradshaw, Adia Radecka, Michael Gallegos, Bryan Kaehr, Holly Golecki
Publikováno v:
Advanced Materials Technologies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a5cc08d587c671d9fba03e0ddf52702
https://doi.org/10.1002/admt.202202034
https://doi.org/10.1002/admt.202202034
Autor:
Hannah Harris, Adia Radecka, Raefa Malik, Roberto Alonso Pineda Guzman, Jeffrey Santoso, Alyssa Bradshaw, Megan McCain, Mariana Kersh, Holly Golecki
Publikováno v:
2022 Design of Medical Devices Conference.
While the field of medical device design has made tremendous progress in recent decades, implantable devices continue to be plagued by the body’s immune response and fibrosis. The field of soft robotics uses low modulus materials that compliance ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17f2f7c151b0138cea4811d11c332234
https://doi.org/10.1115/dmd2022-1049
https://doi.org/10.1115/dmd2022-1049
Autor:
Bryan Kaehr, Georgia Kaufman, Rebecca Tafoya, Michael Gallegos, Holly Golecki, Adia Radecka, Alyssa Bradshaw
Publikováno v:
Proposed for presentation at the MRS Fall Meeting 2021 held November 29-December 2, 2021 in Boston, MA..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c531b371cbb7c8cff28ecae7daa2151
https://doi.org/10.2172/1899671
https://doi.org/10.2172/1899671
Publikováno v:
Transplantation and Cellular Therapy. 27:S457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e92b3cb0ba996decfc67310e952128e4
https://doi.org/10.1016/s2666-6367(21)00592-3
https://doi.org/10.1016/s2666-6367(21)00592-3
Autor:
Kirklin Bowles, Geoffrey Mospan, Alyssa Bradshaw, Shayna Vance, Cortney M. Mospan, Kalyn Meosky
Publikováno v:
The Nurse practitioner. 42(12)
In 2017, the FDA approved several new drugs for use in primary care. This article highlights the following new drugs: brodalumab (Siliq), dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline (Rhofade), safinamide (Xadago), and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64be721804e7591eee0fee56466fe637
https://pubmed.ncbi.nlm.nih.gov/29176433
https://pubmed.ncbi.nlm.nih.gov/29176433
Autor:
Mospan G; Geoffrey Mospan is an assistant professor of pharmacy at Wingate University School of Pharmacy, Wingate, N.C. Cortney Mospan is an assistant professor of pharmacy at Wingate University School of Pharmacy, Wingate, N.C. Shayna Vance is a 4th year PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C. Alyssa Bradshaw is a 4th year PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C. Kalyn Meosky is a 4th year PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C. Kirklin Bowles is a 4th year PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C., Mospan C, Vance S, Bradshaw A, Meosky K, Bowles K
Publikováno v:
The Nurse practitioner [Nurse Pract] 2017 Dec 15; Vol. 42 (12), pp. 8-16.